Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Drug may ease emotional pain after pregnancy loss procedure

NCT ID NCT07537894

First seen Apr 22, 2026 · Last updated Apr 30, 2026 · Updated 2 times

Summary

This study tests whether giving a medicine called dexmedetomidine during a second-trimester dilation and evacuation (D&E) can lower feelings of grief and stress after the procedure. About 100 people having a D&E in the operating room will be randomly assigned to receive the drug or a placebo. The goal is to see if calming the body's stress response during the procedure can prevent severe grief or post-traumatic stress symptoms in the weeks that follow.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for STILLBIRTH are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Stanford Health Care

    Palo Alto, California, 94062, United States

Conditions

Explore the condition pages connected to this study.